Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation

Abstract

A 56-year-old man with behavioural disorders and facial-brachio-crural right hemiparesis presented with a brain lesion studied with computed tomography, magnetic resonance imaging and brain biopsy, leading to the diagnosis of cerebral vasculitis. Hepatitis C virus (HCV) infection in a phase of activity, without cryoglobulins, was also detected. Brain biopsy, laboratory analysis and response to a specific therapy supported the diagnosis of central nervous system vasculitis that was HCV related.

Keywords

Central nervous system cryoglobulin HCV MRI vasculitis

Get full access to this article

View all access options for this article.

References

World Health Organization. Hepatitis C Fact Sheet No. 164, www.who.int/mediacentre/factsheets/fs164/en/ (July 2016, accessed 19 July 2017).

Carvalho-Filho

Narciso-Schiavon

Tolentino

et al.

Central nervous system vasculitis and polyneuropathy as first manifestations of hepatitis C. World J Gastroenterol 2012; 18: 188–191.

Monaco

Mariotto

Ferrari

et al.

Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: advances in 2015. World J Gastroenterol 2015; 21: 11974–11983.

Morra

. Cryoglobulinemia. Hematology Am Soc Hematol Educ Program 2005; 1: 368–372.

Castro Caldas

Geraldes

neto

et al.

Central nervous system vasculitis associated with hepatitis C virus infection: a brain MRI-supported diagnosis. J Neurol Sci 2014; 336: 152–154.

Mathew

Faheem

Ibrahim

et al.

Hepatitis C virus and neurological damage. World J Hepatol 2016; 8: 545–556.

Fletcher

McKeating

. Hepatitis C virus and the brain. J Viral Hepat 2012; 19: 301–306.

Nemni

Sanvito

Quattrini

et al.

Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinemia. J Neurol Neurosurg Psychiatry 2003; 74: 1267–1271.

Ferri

Ramos-Casals

Zignego

et al.

International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev 2016; 15: 1145–1160.